Niki BioSolutions, Inc. Marketable Securities, Unrealized Gain (Loss)
Niki BioSolutions, Inc. (NIKI) reported Marketable Securities, Unrealized Gain (Loss) of -$9.27 thousand for the 12-month period ending 2023-12-31, per its S-4/A filed 2026-05-11.
Financial Statements › Income Statement › Other Income
us-gaap:MarketableSecuritiesUnrealizedGainLoss · last filed 2026-05-11
| Period end | Marketable Securities, Unrealized Gain (Loss) 12 month |
|---|---|
| 2023-12-31 | -$9.27K S-4/A · filed 2026-05-11 |
| 2022-12-31 | -$134.13K 6-K · filed 2025-10-08 |